Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Blog
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA Approves Record Number of Generic Drugs in 2018
Raymond March
-
January 9, 2019
Right-to-try Laws Help Patient with Terminal Brain Cancer
Right-to-Try Legislation Helps Patient Battling Bone Cancer
Deregulation Is the Only Cure for High Drug Prices
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.
Raymond March
-
July 29, 2019
0
FDA Vaping Regulations Will Do More Harm than Good
Raymond March
-
November 30, 2018
0
FDA Still Hooked on Meddling in Nicotine Markets
Raymond March
-
October 8, 2018
0
To Help the Terminally Ill, the FDA Must Deregulate
Raymond March
-
November 14, 2018
0
FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.
Raymond March
-
May 30, 2019
0
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond March
-
September 12, 2018
0
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple...
Raymond March
-
September 26, 2018
0
Open Up Off-Label Drug Communication and Let the Market Work!
Raymond March
-
August 7, 2018
0
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments...
Raymond March
-
May 7, 2019
0
1
2
3
...
9
Page 2 of 9
Edit with Live CSS
